Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
Institute Of Biophysics Chinese Academy Of Sciences manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently contains 3 pending office actions. These 3 actions are assigned to 3 distinct examiners.
The workload is distributed across 2 distinct art units. This means that while there are 3 distinct examiners, at least 2 of them are likely working within the same art unit. The busiest examiner, LEE, MATTHEW Y, is responsible for 1 busiest examiner pending office action.
With 3 pending office actions and 3 distinct examiners, no single individual is handling multiple cases. However, the concentration in 2 distinct art units suggests some thematic overlap in the Biotechnology & Pharmaceuticals filings. Practitioners should be prepared for the specific standards of these 2 distinct art units while addressing the feedback from 3 distinct examiners. This requires a strategy that balances individual examiner styles with the rules of the 2 distinct art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, MATTHEW Y | 1 | 81.5% | +18.3% |
| SKOKO III, JOHN JOSEPH | 1 | 53.1% | +58.2% |
| BERTOGLIO, VALARIE E | 1 | 64.1% | +30.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18866354 | Super-Resolution Single-Objective Light-Sheet Optical Microscopy System and Imaging System Comprising Same | LEE, MATTHEW Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18866354 | Super-Resolution Single-Objective Light-Sheet Optical Microscopy System and Imaging System Comprising Same | LEE, MATTHEW Y | — |
| 18003872 | CONSTRUCTION AND APPLICATION OF FUSION PROTEIN VACCINE PLATFORM | SKOKO III, JOHN JOSEPH | — |
| 17746583 | Method for Inducing Pluripotent Stem Cells to Differentiate into Ventricular Cardiomyocytes In Vitro | BERTOGLIO, VALARIE E | — |
| Art Unit | Apps |
|---|---|
| 1643 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18866354 | Super-Resolution Single-Objective Light-Sheet Optical Microscopy System and Imaging System Comprising Same | LEE, MATTHEW Y | — | §102§103§112 | Non-Final OA | — | Pending | Nov 15, 2024 |
| 18003872 | CONSTRUCTION AND APPLICATION OF FUSION PROTEIN VACCINE PLATFORM | SKOKO III, JOHN JOSEPH | 1643 | §103§112DP | Final Rejection | — | Pending | Dec 29, 2022 |
| 17746583 | Method for Inducing Pluripotent Stem Cells to Differentiate into Ventricular Cardiomyocytes In Vitro | BERTOGLIO, VALARIE E | 1632 | Other | Non-Final OA | — | Pending | May 17, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial